{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T22:04:36Z","timestamp":1793397876814,"version":"4.5.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,6,28]],"date-time":"2022-06-28T00:00:00Z","timestamp":1656374400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,6,28]],"date-time":"2022-06-28T00:00:00Z","timestamp":1656374400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"The Scientific Research Project from Ningxia Province","award":["2020AAC03390"],"award-info":[{"award-number":["2020AAC03390"]}]},{"name":"The Scientific Research Project from Ningxia Province","award":["2020AAC03392"],"award-info":[{"award-number":["2020AAC03392"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["8216090355"],"award-info":[{"award-number":["8216090355"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Orthop Surg Res"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Osteoarthritis (OA) is the most common musculoskeletal disease, and it has a complex pathology and unknown pathogenesis. Chondrocyte ferroptosis is closely associated with the development of OA. As a common drug administered for the treatment of type 2 diabetes, metformin (Met) is known to inhibit the development of ferroptosis. However, its therapeutic effect in OA remains unknown. The present study aimed to explore the effects of Met on cartilage and subchondral bone in a mouse OA model and to explore the potential underlying mechanisms.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>A mouse OA model was induced using destabilization of the medial meniscus (DMM) surgery, chondrocyte ferroptosis was induced using an intra-articular injection of Erastin, and Met (200\u00a0mg\/kg\/day) was intragastrically administered for 8\u00a0weeks after surgery. H&amp;E and Safranin O\u2011fast green staining were used to evaluate cartilage degeneration, and \u03bc\u2011computed tomography was used to evaluate changes in subchondral bone microarchitecture. Moreover, immunohistochemical staining was performed to detect mechanistic metalloproteinases 13, type II collagen, glutathione peroxidase 4, acyl-CoA synthetase long-chain family member 4, solute carrier family 7 member 11 and p53. Runt-associated transcription factor 2 and CD31 were detected using immunofluorescent staining.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Met protected articular cartilage and reversed the abnormal expression of ferroptosis-related proteins in the chondrocytes of DMM mice. Moreover, intra-articular injection of Erastin induced ferroptosis in mouse chondrocytes, and Met eliminated the ferroptosis effects induced by Erastin and protected articular cartilage. In addition, the results of the present study demonstrated that Met alleviated the microstructural changes of subchondral osteosclerosis and reduced heterotypic angiogenesis in DMM mice.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Met alleviates the pathological changes of OA by inhibiting ferroptosis in OA chondrocytes, alleviating subchondral sclerosis and reducing abnormal angiogenesis in subchondral bone in advanced OA.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13018-022-03225-y","type":"journal-article","created":{"date-parts":[[2022,6,28]],"date-time":"2022-06-28T06:03:58Z","timestamp":1656396238000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":61,"title":["Metformin alleviates osteoarthritis in mice by inhibiting chondrocyte ferroptosis and improving subchondral osteosclerosis and angiogenesis"],"prefix":"10.1186","volume":"17","author":[{"given":"Jiangbo","family":"Yan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gangning","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Long","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhirong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qunhua","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,6,28]]},"reference":[{"issue":"4","key":"3225_CR1","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1016\/j.joca.2010.01.013","volume":"18","author":"W Zhang","year":"2010","unstructured":"Zhang W, Nuki G, Moskowitz RW, Abramson S, Altman RD, Arden NK, et al. OARSI recommendations for the management of hip and knee osteoarthritis: part III: changes in evidence following systematic cumulative update of research published through January 2009. Osteoarthr Cartil. 2010;18(4):476\u201399.","journal-title":"Osteoarthr Cartil"},{"key":"3225_CR2","doi-asserted-by":"publisher","first-page":"628330","DOI":"10.3389\/fcell.2021.628330","volume":"9","author":"Z Li","year":"2021","unstructured":"Li Z, Huang Z, Bai L. The P2X7 receptor in osteoarthritis. Front Cell Dev Biol. 2021;9:628330.","journal-title":"Front Cell Dev Biol"},{"issue":"9","key":"3225_CR3","first-page":"646","volume":"81","author":"AD Woolf","year":"2003","unstructured":"Woolf AD, Pfleger B. Burden of major musculoskeletal conditions. Bull World Health Organ. 2003;81(9):646\u201356.","journal-title":"Bull World Health Organ"},{"issue":"7","key":"3225_CR4","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1038\/nrrheum.2014.44","volume":"10","author":"DJ Hunter","year":"2014","unstructured":"Hunter DJ, Schofield D, Callander E. The individual and socioeconomic impact of osteoarthritis. Nat Rev Rheumatol. 2014;10(7):437\u201341.","journal-title":"Nat Rev Rheumatol"},{"issue":"8","key":"3225_CR5","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.3390\/nu10081030","volume":"10","author":"I Morales-Ivorra","year":"2018","unstructured":"Morales-Ivorra I, Romera-Baures M, Roman-Vinas B, Serra-Majem L. Osteoarthritis and the mediterranean diet: a systematic review. Nutrients. 2018;10(8):1030.","journal-title":"Nutrients"},{"issue":"1","key":"3225_CR6","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/nrrheum.2010.178","volume":"7","author":"DJ Hunter","year":"2011","unstructured":"Hunter DJ. Pharmacologic therapy for osteoarthritis\u2013the era of disease modification. Nat Rev Rheumatol. 2011;7(1):13\u201322.","journal-title":"Nat Rev Rheumatol"},{"issue":"1","key":"3225_CR7","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1038\/nrrheum.2010.197","volume":"7","author":"RJ Lories","year":"2011","unstructured":"Lories RJ, Luyten FP. The bone-cartilage unit in osteoarthritis. Nat Rev Rheumatol. 2011;7(1):43\u20139.","journal-title":"Nat Rev Rheumatol"},{"issue":"2","key":"3225_CR8","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.semarthrit.2012.03.009","volume":"42","author":"L Xu","year":"2012","unstructured":"Xu L, Hayashi D, Roemer FW, Felson DT, Guermazi A. Magnetic resonance imaging of subchondral bone marrow lesions in association with osteoarthritis. Semin Arthritis Rheu. 2012;42(2):105\u201318.","journal-title":"Semin Arthritis Rheu"},{"issue":"4","key":"3225_CR9","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1097\/BOR.0000000000000181","volume":"27","author":"T Funck-Brentano","year":"2015","unstructured":"Funck-Brentano T, Cohen-Solal M. Subchondral bone and osteoarthritis. Curr Opin Rheumatol. 2015;27(4):420\u20136.","journal-title":"Curr Opin Rheumatol"},{"issue":"5","key":"3225_CR10","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","volume":"149","author":"SJ Dixon","year":"2012","unstructured":"Dixon SJ, Lemberg KM, Lamprecht MR, Skouta R, Zaitsev EM, Gleason CE, et al. Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell. 2012;149(5):1060\u201372.","journal-title":"Cell"},{"issue":"2","key":"3225_CR11","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.cell.2017.09.021","volume":"171","author":"BR Stockwell","year":"2017","unstructured":"Stockwell BR, Friedmann AJ, Bayir H, Bush AI, Conrad M, Dixon SJ, et al. Ferroptosis: a regulated cell death nexus linking metabolism, redox biology, and disease. Cell. 2017;171(2):273\u201385.","journal-title":"Cell"},{"issue":"1\u20132","key":"3225_CR12","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.cell.2013.12.010","volume":"156","author":"WS Yang","year":"2014","unstructured":"Yang WS, Sriramaratnam R, Welsch ME, Shimada K, Skouta R, Viswanathan VS, et al. Regulation of ferroptotic cancer cell death by GPX4. Cell. 2014;156(1\u20132):317\u201331.","journal-title":"Cell"},{"issue":"5","key":"3225_CR13","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1016\/j.cell.2019.03.032","volume":"177","author":"I Alim","year":"2019","unstructured":"Alim I, Caulfield JT, Chen Y, Swarup V, Geschwind DH, Ivanova E, et al. Selenium drives a transcriptional adaptive program to block ferroptosis and treat stroke. Cell. 2019;177(5):1262\u201379.","journal-title":"Cell"},{"issue":"3","key":"3225_CR14","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.cell.2017.11.048","volume":"172","author":"I Ingold","year":"2018","unstructured":"Ingold I, Berndt C, Schmitt S, Doll S, Poschmann G, Buday K, et al. Selenium utilization by GPX4 Is required to prevent hydroperoxide-induced ferroptosis. Cell. 2018;172(3):409\u201322.","journal-title":"Cell"},{"issue":"3","key":"3225_CR15","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1016\/j.bbrc.2016.08.124","volume":"478","author":"H Yuan","year":"2016","unstructured":"Yuan H, Li X, Zhang X, Kang R, Tang D. Identification of ACSL4 as a biomarker and contributor of ferroptosis. Biochem Biophys Res Commun. 2016;478(3):1338\u201343.","journal-title":"Biochem Biophys Res Commun"},{"issue":"5","key":"3225_CR16","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1089\/ars.2011.4391","volume":"18","author":"J Lewerenz","year":"2013","unstructured":"Lewerenz J, Hewett SJ, Huang Y, Lambros M, Gout PW, Kalivas PW, et al. The cystine\/glutamate antiporter system x(c)(-) in health and disease: from molecular mechanisms to novel therapeutic opportunities. Antioxid Redox Signal. 2013;18(5):522\u201355.","journal-title":"Antioxid Redox Signal"},{"issue":"7545","key":"3225_CR17","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/nature14344","volume":"520","author":"L Jiang","year":"2015","unstructured":"Jiang L, Kon N, Li T, Wang SJ, Su T, Hibshoosh H, et al. Ferroptosis as a p53-mediated activity during tumour suppression. Nature. 2015;520(7545):57\u201362.","journal-title":"Nature"},{"key":"3225_CR18","doi-asserted-by":"publisher","first-page":"594509","DOI":"10.3389\/fcell.2020.594509","volume":"8","author":"X Jing","year":"2020","unstructured":"Jing X, Lin J, Du T, Jiang Z, Li T, Wang G, et al. Iron overload is associated with accelerated progression of osteoarthritis: the role of DMT1 mediated iron homeostasis. Front Cell Dev Biol. 2020;8:594509.","journal-title":"Front Cell Dev Biol"},{"issue":"4","key":"3225_CR19","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1177\/1759720X12437353","volume":"4","author":"SR Goldring","year":"2012","unstructured":"Goldring SR. Alterations in periarticular bone and cross talk between subchondral bone and articular cartilage in osteoarthritis. Ther Adv Musculoskel. 2012;4(4):249\u201358.","journal-title":"Ther Adv Musculoskel"},{"issue":"12","key":"3225_CR20","doi-asserted-by":"publisher","first-page":"3178","DOI":"10.1002\/art.10630","volume":"46","author":"P Bettica","year":"2002","unstructured":"Bettica P, Cline G, Hart DJ, Meyer J, Spector TD. Evidence for increased bone resorption in patients with progressive knee osteoarthritis: longitudinal results from the Chingford study. Arthritis Rheum. 2002;46(12):3178\u201384.","journal-title":"Arthritis Rheum"},{"issue":"340","key":"3225_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3109\/17453671003619037","volume":"81","author":"M Ding","year":"2010","unstructured":"Ding M. Microarchitectural adaptations in aging and osteoarthrotic subchondral bone issues. Acta Orthop Suppl. 2010;81(340):1\u201353.","journal-title":"Acta Orthop Suppl"},{"issue":"2","key":"3225_CR22","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1002\/jor.23009","volume":"34","author":"J Geurts","year":"2016","unstructured":"Geurts J, Patel A, Hirschmann MT, Pagenstert GI, Muller-Gerbl M, Valderrabano V, et al. Elevated marrow inflammatory cells and osteoclasts in subchondral osteosclerosis in human knee osteoarthritis. J Orthop Res. 2016;34(2):262\u20139.","journal-title":"J Orthop Res"},{"issue":"3","key":"3225_CR23","doi-asserted-by":"publisher","first-page":"222","DOI":"10.3892\/etm.2022.11146","volume":"23","author":"J Yan","year":"2022","unstructured":"Yan J, Ding D, Feng G, Yang Y, Zhou Y, Ma L, et al. Metformin reduces chondrocyte pyroptosis in an osteoarthritis mouse model by inhibiting NLRP3 inflammasome activation. Exp Ther Med. 2022;23(3):222.","journal-title":"Exp Ther Med"},{"issue":"3","key":"3225_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3892\/ijmm.2021.4855","volume":"47","author":"L Ma","year":"2021","unstructured":"Ma L, Zhao X, Liu Y, Wu J, Yang X, Jin Q. Dihydroartemisinin attenuates osteoarthritis by inhibiting abnormal bone remodeling and angiogenesis in subchondral bone. Int J Mol Med. 2021;47(3):1.","journal-title":"Int J Mol Med"},{"issue":"11","key":"3225_CR25","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1136\/ard.2006.063354","volume":"66","author":"S Suri","year":"2007","unstructured":"Suri S, Gill SE, Massena De Camin S, Wilson D, Mcwilliams DF, Walsh DA. Neurovascular invasion at the osteochondral junction and in osteophytes in osteoarthritis. Ann Rheum Dis. 2007;66(11):1423\u20138.","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"3225_CR26","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1093\/rheumatology\/keh344","volume":"44","author":"CS Bonnet","year":"2005","unstructured":"Bonnet CS, Walsh DA. Osteoarthritis, angiogenesis and inflammation. Rheumatology. 2005;44(1):7\u201316.","journal-title":"Rheumatology"},{"issue":"4","key":"3225_CR27","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/j.joca.2009.12.006","volume":"18","author":"PI Mapp","year":"2010","unstructured":"Mapp PI, Walsh DA, Bowyer J, Maciewicz RA. Effects of a metalloproteinase inhibitor on osteochondral angiogenesis, chondropathy and pain behavior in a rat model of osteoarthritis. Osteoarthr Cartil. 2010;18(4):593\u2013600.","journal-title":"Osteoarthr Cartil"},{"key":"3225_CR28","doi-asserted-by":"publisher","first-page":"191","DOI":"10.3389\/fendo.2020.00191","volume":"11","author":"Z Lv","year":"2020","unstructured":"Lv Z, Guo Y. Metformin and Its benefits for various diseases. Front Endocrinol. 2020;11:191.","journal-title":"Front Endocrinol"},{"issue":"6","key":"3225_CR29","first-page":"1202","volume":"15","author":"H Soraya","year":"2012","unstructured":"Soraya H, Esfahanian N, Shakiba Y, Ghazi-Khansari M, Nikbin B, Hafezzadeh H, et al. Anti-angiogenic effects of metformin, an AMPK activator, on human umbilical vein endothelial cells and on granulation tissue in rat. Iran J Basic Med Sci. 2012;15(6):1202\u20139.","journal-title":"Iran J Basic Med Sci"},{"issue":"3","key":"3225_CR30","doi-asserted-by":"publisher","first-page":"e193031","DOI":"10.1371\/journal.pone.0193031","volume":"13","author":"J Han","year":"2018","unstructured":"Han J, Li Y, Liu X, Zhou T, Sun H, Edwards P, et al. Metformin suppresses retinal angiogenesis and inflammation in vitro and in vivo. PLoS ONE. 2018;13(3):e193031.","journal-title":"PLoS ONE"},{"issue":"1","key":"3225_CR31","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1186\/s13046-019-1469-4","volume":"38","author":"WJ Bae","year":"2019","unstructured":"Bae WJ, Ahn JM, Byeon HE, Kim S, Lee D. PTPRD-inactivation-induced CXCL8 promotes angiogenesis and metastasis in gastric cancer and is inhibited by metformin. J Exp Clin Cancer Res. 2019;38(1):484.","journal-title":"J Exp Clin Cancer Res"},{"issue":"1","key":"3225_CR32","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1186\/s13075-019-1915-x","volume":"21","author":"Y Wang","year":"2019","unstructured":"Wang Y, Hussain SM, Wluka AE, Lim YZ, Abram F, Pelletier JP, et al. Association between metformin use and disease progression in obese people with knee osteoarthritis: data from the Osteoarthritis Initiative\u2014a prospective cohort study. Arthritis Res Ther. 2019;21(1):127.","journal-title":"Arthritis Res Ther"},{"key":"3225_CR33","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.freeradbiomed.2021.01.033","volume":"165","author":"WQ Ma","year":"2021","unstructured":"Ma WQ, Sun XJ, Zhu Y, Liu NF. Metformin attenuates hyperlipidaemia-associated vascular calcification through anti-ferroptotic effects. Free Radic Biol Med. 2021;165:229\u201342.","journal-title":"Free Radic Biol Med"},{"issue":"1","key":"3225_CR34","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1186\/s13046-021-02012-7","volume":"40","author":"J Yang","year":"2021","unstructured":"Yang J, Zhou Y, Xie S, Wang J, Li Z, Chen L, et al. Metformin induces ferroptosis by inhibiting UFMylation of SLC7A11 in breast cancer. J Exp Clin Cancer Res. 2021;40(1):206.","journal-title":"J Exp Clin Cancer Res"},{"issue":"4","key":"3225_CR35","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.joca.2012.02.010","volume":"20","author":"C Kilkenny","year":"2012","unstructured":"Kilkenny C, Browne WJ, Cuthill IC, Emerson M, Altman DG. Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research. Osteoarthr Cartil. 2012;20(4):256\u201360.","journal-title":"Osteoarthr Cartil"},{"issue":"4","key":"3225_CR36","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1080\/08916934.2019.1643844","volume":"52","author":"G Xu","year":"2019","unstructured":"Xu G, Wang J, Ma L, Zhao X, Luo W, Jin Q. Local intra-articular injection of rapamycin inhibits NLRP3 activity and prevents osteoarthritis in mouse DMM models. Autoimmunity. 2019;52(4):168\u201375.","journal-title":"Autoimmunity"},{"issue":"12","key":"3225_CR37","doi-asserted-by":"publisher","first-page":"e261127","DOI":"10.1371\/journal.pone.0261127","volume":"16","author":"H Guo","year":"2021","unstructured":"Guo H, Ding D, Wang L, Yan J, Ma L, Jin Q. Metformin attenuates osteoclast-mediated abnormal subchondral bone remodeling and alleviates osteoarthritis via AMPK\/NF-kappaB\/ERK signaling pathway. PLoS ONE. 2021;16(12):e261127.","journal-title":"PLoS ONE"},{"key":"3225_CR38","doi-asserted-by":"publisher","first-page":"791376","DOI":"10.3389\/fphar.2022.791376","volume":"13","author":"Z Guo","year":"2022","unstructured":"Guo Z, Lin J, Sun K, Guo J, Yao X, Wang G, et al. Deferoxamine alleviates osteoarthritis by inhibiting chondrocyte ferroptosis and activating the Nrf2 pathway. Front Pharmacol. 2022;13:791376.","journal-title":"Front Pharmacol"},{"issue":"Suppl 3","key":"3225_CR39","doi-asserted-by":"publisher","first-page":"S17","DOI":"10.1016\/j.joca.2010.05.025","volume":"18","author":"SS Glasson","year":"2010","unstructured":"Glasson SS, Chambers MG, Van Den Berg WB, Little CB. The OARSI histopathology initiative-recommendations for histological assessments of osteoarthritis in the mouse. Osteoarthr Cartil. 2010;18(Suppl 3):S17\u201323.","journal-title":"Osteoarthr Cartil"},{"issue":"11","key":"3225_CR40","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1016\/j.joca.2011.08.009","volume":"19","author":"D Pereira","year":"2011","unstructured":"Pereira D, Peleteiro B, Araujo J, Branco J, Santos RA, Ramos E. The effect of osteoarthritis definition on prevalence and incidence estimates: a systematic review. Osteoarthr Cartil. 2011;19(11):1270\u201385.","journal-title":"Osteoarthr Cartil"},{"issue":"9","key":"3225_CR41","doi-asserted-by":"publisher","first-page":"20560","DOI":"10.3390\/ijms160920560","volume":"16","author":"G Musumeci","year":"2015","unstructured":"Musumeci G, Castrogiovanni P, Trovato FM, Weinberg AM, Al-Wasiyah MK, Alqahtani MH, et al. Biomarkers of chondrocyte apoptosis and autophagy in osteoarthritis. Int J Mol Sci. 2015;16(9):20560\u201375.","journal-title":"Int J Mol Sci"},{"key":"3225_CR42","first-page":"33","volume":"27","author":"X Yao","year":"2021","unstructured":"Yao X, Sun K, Yu S, Luo J, Guo J, Lin J, et al. Chondrocyte ferroptosis contribute to the progression of osteoarthritis. J Orthop Transl. 2021;27:33\u201343.","journal-title":"J Orthop Transl"},{"key":"3225_CR43","first-page":"5720360","volume":"2020","author":"X Zhou","year":"2020","unstructured":"Zhou X, Cao H, Yuan Y, Wu W. Biochemical signals mediate the crosstalk between cartilage and bone in osteoarthritis. Biomed Res Int. 2020;2020:5720360.","journal-title":"Biomed Res Int"},{"issue":"1","key":"3225_CR44","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1186\/s12891-021-04516-x","volume":"22","author":"X Hu","year":"2021","unstructured":"Hu X, Feng G, Meng Z, Ma L, Jin Q. The protective mechanism of SIRT1 on cartilage through regulation of LEF-1. BMC Musculoskelet Disord. 2021;22(1):642.","journal-title":"BMC Musculoskelet Disord"}],"container-title":["Journal of Orthopaedic Surgery and Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13018-022-03225-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13018-022-03225-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13018-022-03225-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,23]],"date-time":"2022-10-23T01:08:54Z","timestamp":1666487334000},"score":1,"resource":{"primary":{"URL":"https:\/\/josr-online.biomedcentral.com\/articles\/10.1186\/s13018-022-03225-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,28]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["3225"],"URL":"https:\/\/doi.org\/10.1186\/s13018-022-03225-y","relation":{},"ISSN":["1749-799X"],"issn-type":[{"value":"1749-799X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,28]]},"assertion":[{"value":"9 June 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 June 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The experimental procedures were carried out in accordance with the National Institutes of Health Guide for the Care and Use of Laboratory Animals and were approved by the Animal Ethics Committee of Ningxia Medical University (Yinchuan, China; protocol no. 2020-115).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"333"}}